CLYM · Forms 3, 4, 5
Insider trades at Climb Bio, Inc.
1 insider sold $1.4M of Climb Bio, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Climb Bio, Inc. (CLYM) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director | Option exercise | 10,000 | $3.46 | $35K | Form 4 | |
| RA CAPITAL MANAGEMENT, L.P. | Director | Option exercise | 10,000 | $3.00 | $30K | Form 4 | |
| RA CAPITAL MANAGEMENT, L.P. | Director | Option exercise | 10,000 | $7.89 | $79K | Form 4 | |
| RA CAPITAL MANAGEMENT, L.P. | Director | Option exercise | 40,000 | $1.29 | $52K | Form 4 | |
| Stephen Basil Thomas | Director | Sell | 100,000 | $13.67 | $1.4M | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.